Fibromyalgia: Causes, Diagnosis, and the Complete Treatment Guide

Fibromyalgia is caused by central sensitization, a lasting change in how the brain and spinal cord process pain signals, which usually develops when an inherited vulnerability meets a trigger such as physical injury, infection or prolonged stress. No single cause has been found, but first-degree relatives of people with fibromyalgia carry about eight times the usual risk, and a 2019 meta-analysis by Grayston and colleagues found small-fiber nerve changes in 49% of patients.

---

If you’ve been told your pain “doesn’t make sense,” that your labs are “all normal,” or, worst of all, that you’re simply anxious or depressed, you are not alone. Fibromyalgia is one of the most misunderstood conditions in modern medicine, and the gap between what science actually knows and what many patients hear in a seven-minute office visit is enormous.

Here is what the research clearly shows: fibromyalgia is a disorder of central pain processing. The nervous system has become stuck in a state of hyper-vigilance, turning up the volume on pain signals while simultaneously dampening the body’s built-in pain-dampening circuits. Brain imaging, spinal-fluid analyses, and small-fiber nerve studies have confirmed measurable, objective differences in people with fibromyalgia. This is not a diagnosis of convenience. It is a real neurological condition, and it deserves a real treatment strategy.

What follows starts with what causes fibromyalgia, then moves through how it is diagnosed, what conventional medicine offers, and where integrative and regenerative therapies fit in. Every treatment carries an evidence grade (established, promising or early research) so you can weigh it honestly with your care team.

What Causes Fibromyalgia? Risk Factors and Triggers

Fibromyalgia is caused by central sensitization, a state in which the nervous system amplifies pain signals and loses some of its ability to dampen them. Researchers do not know a single cause, and there probably isn’t one. Fibromyalgia appears to result from a convergence of predisposing factors, triggering events, and perpetuating mechanisms:

Predisposing factors:

• Genetic vulnerability, first-degree relatives of fibromyalgia patients have an 8× increased risk. Polymorphisms in genes related to serotonin, catecholamine, and dopamine metabolism have been identified.
• Female sex, hormonal and neuroimmune differences likely contribute
• Early-life adverse experiences, childhood trauma and chronic stress alter HPA axis function and pain processing

Common triggering events:

• Physical trauma (car accidents, surgery, injury)
• Severe emotional stress (bereavement, divorce, job loss)
• Infections (EBV, Lyme disease, hepatitis C, COVID-19)
• Autoimmune disease onset (lupus, rheumatoid arthritis)

Perpetuating factors:

• Ongoing sleep disruption
• Physical deconditioning
• Untreated comorbidities (SIBO, MCAS, hypothyroidism)
• Chronic psychological stress
• Gut dysbiosis and systemic inflammation

The table below sorts the main causes of fibromyalgia by how strong the evidence for each one is today.

Is fibromyalgia genetic?

Fibromyalgia runs in families. A family study by Arnold and colleagues (Arthritis & Rheumatism, 2004) found that first-degree relatives of people with fibromyalgia were about eight times more likely to have it than relatives of people with rheumatoid arthritis. Genes set the threshold, not the outcome: many people with an affected parent never develop fibromyalgia, which points to triggers and environment as the second half of the story.

Can an injury, infection or stress trigger fibromyalgia?

Physical trauma, surgery, viral infections and severe emotional stress are the triggers patients and clinicians report most often. Infections linked to fibromyalgia onset include Epstein-Barr virus, Lyme disease, hepatitis C and COVID-19, and the overlap with long COVID is under active study. The trigger seems to tip an already sensitive nervous system into a persistent amplified state, rather than cause damage directly.

Is fibromyalgia caused by inflammation or the immune system?

Fibromyalgia is not classed as an autoimmune or inflammatory joint disease, and routine markers such as ESR and CRP are usually normal. Research is shifting, though. Goebel and colleagues (Journal of Clinical Investigation, 2021) showed that IgG antibodies from fibromyalgia patients transferred pain hypersensitivity to mice, and PET imaging studies describe glial activation in the brain. A more detailed walk through each proposed mechanism is in our post on fibromyalgia causes and risk factors.

What does not cause fibromyalgia?

Fibromyalgia is not caused by muscle damage, joint destruction or a character weakness. Depression and anxiety often travel with it, in 30-50% of patients, but they are comorbidities rather than the root cause, and treating mood alone rarely removes the pain. Fibromyalgia is also not a diagnosis of exclusion: it has its own positive criteria, covered in the diagnosis section below.

The Three Pillars of Fibromyalgia

Fibromyalgia is far more than “body pain.” The condition is best understood as a triad, three overlapping symptom domains that feed off each other in a vicious cycle.

Understanding this triad matters because effective treatment must address all three domains, not just pain.

Fibro fog deserves its own attention because it shapes work, driving and relationships. Poor sleep, pain load, medication side effects and low iron or B12 all add to it, so a careful workup looks for each of these before blaming fibromyalgia alone. Practical strategies and the research behind them are covered in our post on fibromyalgia brain fog.

The Central Sensitization Mechanism: Why Everything Hurts

To understand fibromyalgia, you need to understand a concept called central sensitization. In a healthy nervous system, pain signals travel from peripheral nerves up through the spinal cord to the brain, where they are processed, modulated, and, when appropriate, dampened. Your brain has powerful descending inhibitory pathways that essentially turn the volume down on incoming pain signals. Think of it as a built-in noise-canceling system.

In fibromyalgia, that system malfunctions in multiple ways:

• Pain amplification: Dorsal horn neurons in the spinal cord become hyper-excitable. They fire more frequently and more intensely in response to the same stimulus. This is called “wind-up.”
• Lowered pain threshold: The point at which a stimulus is perceived as painful drops dramatically. Functional MRI studies confirm that fibromyalgia patients show pain-related brain activation at pressure levels that don’t register as painful in controls.
• Altered neurotransmitters: Spinal fluid studies show elevated levels of substance P (a pain-transmitting neuropeptide), sometimes 2-3× normal, alongside reduced levels of serotonin, norepinephrine, and dopamine, which are critical for descending pain inhibition.
• Glial cell activation: Emerging PET imaging research shows activated glial cells (the brain’s immune cells) in multiple brain regions in fibromyalgia patients, suggesting a neuroinflammatory component.
• Small-fiber neuropathy overlap: Up to 50% of fibromyalgia patients show reduced small-fiber nerve density on skin biopsy; a 2019 meta-analysis by Grayston and colleagues put the pooled prevalence at 49%, suggesting a peripheral nerve component in at least a subset of patients. Learn more in our small-fiber neuropathy guide.

The practical takeaway: fibromyalgia pain is generated and maintained by the nervous system itself. The muscles and joints may feel like they are on fire, but the core problem is in the way the brain and spinal cord process signals. This is why treatments that target the nervous system, from specific medications to neurofeedback to vagus nerve stimulation, can help where painkillers aimed at muscles and joints fall short.

Diagnosing Fibromyalgia: The 2016 ACR Criteria

There is no blood test, imaging scan, or biopsy that definitively confirms fibromyalgia. Diagnosis is clinical, meaning it’s based on a structured evaluation of your symptoms, their distribution, and their duration.

The current gold standard is the 2016 revised American College of Rheumatology (ACR) criteria, published by Wolfe and colleagues in Seminars in Arthritis and Rheumatism, which use two validated tools:

Widespread Pain Index (WPI)

You identify how many of 19 specified body areas have been painful over the past week. Each area scores 1 point. Score range: 0-19.

Symptom Severity Scale (SSS)

You rate the severity (0-3) of three symptoms, fatigue, waking unrefreshed, and cognitive symptoms, plus the presence of additional somatic symptoms (headaches, abdominal pain, depression). Score range: 0-12.

Diagnostic Thresholds

Your doctor should also run baseline labs, CBC, CMP, TSH, ESR/CRP, vitamin D, ferritin, and ANA, not to “prove” fibromyalgia, but to identify treatable comorbidities and rule out conditions that mimic it (hypothyroidism, lupus, rheumatoid arthritis, multiple sclerosis).

A second framework, the AAPT diagnostic criteria (ACTTION and the American Pain Society, published by Arnold and colleagues in 2019), defines fibromyalgia as pain in at least 6 of 9 body sites plus moderate to severe sleep problems or fatigue for at least 3 months. Both systems reach the same conclusion: fibromyalgia is diagnosed from its own pattern of symptoms, not by elimination.

Who diagnoses fibromyalgia?

Rheumatologists diagnose most complex cases, but primary care physicians can and often do make the diagnosis using the ACR criteria. Neurologists, pain medicine specialists and physical medicine and rehabilitation physicians (physiatrists) are often involved when nerve symptoms, small-fiber neuropathy or function are the main concern. A clinician who uses the WPI and SSS scores, rather than a tender point exam alone, is applying the current standard.

Fibromyalgia vs. Lupus: How to Tell the Difference

This is one of the most commonly searched comparisons, and for good reason. Both cause widespread pain, fatigue, and cognitive problems. But they are fundamentally different conditions. A longer side-by-side, including which antibody tests matter, is in our post on fibromyalgia vs lupus.

Common Comorbidities: The Conditions That Travel With Fibromyalgia

Fibromyalgia rarely travels alone. If you have fibromyalgia, there is a significantly elevated chance you also have one or more of the following conditions, and treating them can meaningfully reduce your overall symptom burden:

• Mast Cell Activation Syndrome (MCAS): Emerging research suggests mast cell dysfunction may drive neuroinflammation in a subset of fibromyalgia patients. Symptoms overlap significantly, pain, fatigue, brain fog, gut problems, flushing.
• POTS (Postural Orthostatic Tachycardia Syndrome): Autonomic dysfunction is common in fibromyalgia. If you get dizzy on standing, feel your heart racing, or experience exercise intolerance disproportionate to your fitness level, a tilt-table test is warranted.
• Ehlers-Danlos Syndrome (hypermobile type): Hypermobility, chronic pain, and dysautonomia frequently cluster together. The biomechanical stress of joint hypermobility may contribute to peripheral nociceptive input that maintains central sensitization.
• SIBO (Small Intestinal Bacterial Overgrowth): Studies suggest SIBO prevalence in fibromyalgia patients may be as high as 100% in some cohorts. We discuss this in detail below.
• Hypothyroidism: Both overt and subclinical hypothyroidism share multiple symptoms with fibromyalgia. Always check a full thyroid panel (TSH, free T4, free T3, thyroid antibodies), not just TSH.
• Depression and anxiety: Present in 30-50% of fibromyalgia patients. These are comorbidities, not causes. Treating mood disorders improves quality of life but does not eliminate fibromyalgia pain.
• Irritable Bowel Syndrome (IBS): Up to 70% of fibromyalgia patients meet irritable bowel syndrome criteria. Both conditions share a central sensitization component.
• Migraine: Central sensitization also drives chronic migraine. The overlap is so strong that some researchers consider fibromyalgia and chronic migraine part of the same “central sensitivity syndrome” spectrum.

Conventional Treatments: What the Evidence Actually Says

Let’s start with the treatments that have the largest body of evidence behind them. These are not necessarily the “best” treatments, but they are the most studied, and any fibromyalgia treatment plan should at least consider them.

The EULAR revised recommendations for fibromyalgia (Macfarlane and colleagues, Annals of the Rheumatic Diseases, 2017) remain the most cited guideline. They gave a strong recommendation to only one treatment, exercise, and weak recommendations to CBT, mindful movement such as tai chi and yoga, acupuncture and hydrotherapy, with duloxetine, pregabalin, milnacipran, amitriptyline and cyclobenzaprine reserved for people with severe pain or sleep problems. A plain-language overview of conventional and integrative options sits in our fibromyalgia treatment guide.

FDA-Approved Medications

The FDA approved pregabalin for fibromyalgia in 2007, duloxetine in 2008 and milnacipran in 2009. Off-label options with supporting trials include low-dose amitriptyline and cyclobenzaprine at bedtime, mainly for sleep, and gabapentin as a cheaper relative of pregabalin.

An honest note about these medications: they help, but their effect sizes are modest. In large clinical trials, about 30-40% of patients experience meaningful (≥30%) pain reduction. They work best as one layer in a multimodal strategy, not as standalone solutions.

Exercise: The Single Strongest Treatment

ESTABLISHED, Strongest evidence of any fibromyalgia intervention

This is the part where many patients understandably push back. “How can I exercise when it hurts to walk across the room?” It is a legitimate concern, and the answer is that exercise for fibromyalgia must be approached completely differently than exercise for general fitness.

The evidence is unequivocal: aerobic exercise, strength training, and aquatic exercise all improve pain, fatigue, mood, and physical function in fibromyalgia. Meta-analyses consistently rank exercise as producing effect sizes equal to or greater than any medication. The key principles:

• Start absurdly low. Five minutes of gentle walking. Two minutes on a recumbent bike. The goal is to exercise below your symptom flare threshold.
• Progress absurdly slowly. Increase duration by no more than 10% per week. If you flare, drop back and hold steady for two weeks before trying to progress again.
• Warm water exercise is ideal for beginners. Pool temperatures of 33-35°C (91-95°F) reduce pain perception and allow movement that would be impossible on land.
• Consistency beats intensity. Three 20-minute sessions per week serve the nervous system far better than one 60-minute session. The nervous system needs repeated, gentle exposure to movement to recalibrate.
• The first 4-6 weeks are the hardest. Initial symptom flares are common and expected. Many patients who keep going through this period with careful pacing report meaningful improvement by week 8-12.

Cognitive Behavioral Therapy (CBT) for Chronic Pain

ESTABLISHED

CBT for chronic pain is not about being told that your pain is psychological. It is a structured, skills-based therapy that helps you modify the cognitive and behavioral patterns that amplify central sensitization. Pain catastrophizing, the tendency to ruminate on pain, magnify its threat, and feel helpless about it, is a powerful predictor of pain severity and disability in fibromyalgia. CBT directly reduces catastrophizing, and meta-analyses show moderate effect sizes for pain reduction, improved function, and better mood.

Look specifically for a therapist trained in CBT for chronic pain or pain management, not general CBT. Acceptance and Commitment Therapy (ACT) is a closely related approach with emerging evidence in fibromyalgia as well.

Integrative and Regenerative Approaches

These treatments sit at the frontier of fibromyalgia care. Some have promising clinical trial data; others are based on strong mechanistic rationale and clinical observation but need larger studies. We grade each one honestly.

Low-Dose Naltrexone (LDN)

PROMISING

Low-dose naltrexone (typically 1.5-4.5 mg at bedtime) works through a completely different mechanism than full-dose naltrexone. At low doses, it transiently blocks opioid receptors, leading to a rebound upregulation of endogenous endorphins and enkephalins. More importantly, it modulates microglial activation, calming the neuroinflammatory cascade that drives central sensitization.

Multiple small randomized controlled trials (RCTs) have been published, and their results point in different directions. A Stanford pilot study by Younger and Mackey (2009) reported a 30% symptom reduction compared to placebo. Their 2013 crossover trial in 31 women found baseline pain fell 28.8% on 4.5 mg LDN versus 18.0% on placebo, with better mood and life satisfaction but no change in fatigue or sleep. A larger Danish trial by Bruun and colleagues (The Lancet Rheumatology, 2024) gave 6 mg LDN or placebo to 99 women for 12 weeks and found no significant difference in pain, though memory symptoms may have improved. Side effects are usually mild, vivid dreams and mild headache during the first week are the most commonly reported.

LDN is not FDA-approved for fibromyalgia and must be obtained from a compounding pharmacy. Its low cost and mild side effect profile keep it on the table for many patients, but the mixed trial results mean it is best treated as a reasonable experiment with a clear stop point, not a sure thing. Our post on LDN for fibromyalgia covers dosing schedules and what to track.

NAD+ IV Therapy

EARLY RESEARCH

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential for mitochondrial energy production, DNA repair, and sirtuin activation. The hypothesis: fibromyalgia involves mitochondrial dysfunction and impaired cellular energy production, and restoring NAD+ levels via IV infusion may improve fatigue and cognitive function. Clinical data specific to fibromyalgia is very limited, mostly case series and anecdotal reports. This is a biologically plausible intervention that needs rigorous study. NAD+ infusions are cash pay and take hours per session; the NAD+ IV therapy guide explains what an infusion involves and what the broader evidence looks like.

Neurofeedback

PROMISING

Neurofeedback is a form of EEG biofeedback that trains the brain to modify its own electrical activity patterns. Multiple studies have shown that fibromyalgia patients have characteristic EEG abnormalities, increased theta activity, altered alpha rhythms, and disrupted sensorimotor rhythm (SMR). Neurofeedback protocols targeting these patterns have shown clinically meaningful improvements in pain, brain fog, and sleep quality in several controlled studies. A 2017 randomized trial demonstrated significant pain reduction sustained at 6-month follow-up. The treatment is non-invasive and low risk; temporary headache, tiredness or trouble sleeping after a session are the most common complaints. Neurofeedback is usually cash pay, and practitioner training varies, so ask who designs the protocol. You can compare providers in the neurofeedback clinic directory.

Hyperbaric Oxygen Therapy (HBOT)

PROMISING

The most compelling data comes from Israeli research groups. A 2015 randomized crossover trial by Efrati et al. in 60 women, published in PLoS One, showed that 40 sessions of HBOT (2 ATA, 90 minutes) produced significant improvements in pain, fatigue, cognitive function, and quality of life, with SPECT imaging confirming changes in brain perfusion patterns. A follow-up study showed sustained benefits at 2 years. The proposed mechanism: HBOT reduces neuroinflammation, promotes neuroplasticity, and improves oxygen delivery to hypoperfused brain regions. The main barriers are cost and time commitment (40 sessions over 8 weeks).

Fibromyalgia is not on the FDA-cleared or Undersea and Hyperbaric Medical Society (UHMS) approved list of hyperbaric indications, so insurance rarely pays and treatment is almost always cash pay. Ask any clinic whether it uses a hard-shell chamber at 2 ATA, as in the trials, or a soft-shell mild chamber at lower pressure, which has not been tested in the same way. The hyperbaric oxygen therapy treatment guide covers pressures, side effects such as ear barotrauma, and who should avoid HBOT, and the directory of HBOT clinics lists centers by state.

Peptide Therapy

EARLY RESEARCH

Several therapeutic peptides are being explored in the context of fibromyalgia and central sensitization, including BPC-157 (for its anti-inflammatory and neurotropic properties), thymosin alpha-1 (for immune modulation), and KPV (for its anti-inflammatory effects via alpha-MSH pathways). Clinical evidence specific to fibromyalgia is almost entirely preclinical and anecdotal at this point. These agents are biologically interesting but should be considered experimental.

Vagus Nerve Stimulation (VNS)

PROMISING

The vagus nerve is the primary parasympathetic nerve, the “brake pedal” of the autonomic nervous system. Fibromyalgia is associated with sympathetic dominance and reduced vagal tone. Non-invasive transcutaneous vagus nerve stimulation (tVNS) devices have shown significant improvements in pain and fatigue in fibromyalgia pilot studies. A 2019 study using auricular tVNS showed 35% pain reduction after 2 weeks. This approach directly targets the autonomic dysfunction that perpetuates central sensitization.

Therapeutic Plasma Exchange (TPE)

EARLY RESEARCH

Therapeutic plasma exchange (TPE, also called plasmapheresis) removes a patient’s plasma, along with the antibodies in it, and replaces it with albumin or donor plasma. Interest in TPE for fibromyalgia and fibro fog comes from the 2021 Goebel finding that patient IgG can transfer pain sensitivity to mice, which suggests that lowering antibody levels might help a subset of patients. That remains a hypothesis: TPE has no established evidence base in fibromyalgia, and it should be considered experimental for this use.

TPE side effects are well documented from its standard uses. They include low blood pressure during the procedure, tingling or muscle cramps from the citrate anticoagulant lowering calcium, bruising or bleeding, infection or clotting at the catheter site, and allergic reactions to replacement fluids. In multiple sclerosis, TPE is an established second-line option for severe relapses that do not respond to steroids, which is a different situation from fibromyalgia. Cost depends on the setting and the number of exchanges, and for fibromyalgia it is cash pay. Our post on therapeutic plasma exchange explains how the procedure works, and the multiple sclerosis condition page covers its role in MS.

Treatment Comparison: Head to Head

Diet and Fibromyalgia: What Actually Matters

Nutritional interventions won’t replace the core treatment strategies above, but they can meaningfully reduce the inflammatory and metabolic burden that contributes to central sensitization. Diet research in fibromyalgia is mostly small and short, so treat each change as a trial you measure. Meal patterns, food lists and the studies behind them are covered in our fibromyalgia diet post.

Anti-Inflammatory Diet

The evidence supports a whole-foods, plant-rich, minimally processed diet, essentially a Mediterranean-style pattern. Key principles:

• Emphasize omega-3-rich foods (fatty fish, walnuts, flaxseed) over omega-6-dominant seed oils
• Reduce or eliminate added sugars and ultra-processed foods, which activate inflammatory pathways
• Include polyphenol-rich foods (berries, green tea, turmeric, dark leafy greens) for their anti-inflammatory and antioxidant effects
• Consider reducing gluten and dairy for a 4-6 week trial, a subset of fibromyalgia patients report significant symptom improvement, possibly related to gut permeability

Elimination Diet

A structured elimination diet, removing the most common trigger foods (gluten, dairy, soy, corn, eggs, nightshades) for 4-6 weeks, then systematically reintroducing them, can identify individual food sensitivities. This is particularly relevant if you have significant IBS-type symptoms alongside your fibromyalgia. Work with a registered dietitian to ensure nutritional adequacy.

Vitamin D Optimization

Vitamin D deficiency is remarkably common in fibromyalgia patients, some studies report rates as high as 40-70%. Low vitamin D is associated with increased pain sensitivity, fatigue, and depression. While supplementation studies show mixed results for pain, optimizing vitamin D to a serum level of 40-60 ng/mL is a low-risk intervention that addresses a common deficiency in this population. The right dose depends on your starting blood level, so test first and retest after about three months; many clinicians pair vitamin D with vitamin K2 for calcium metabolism.

The Fibro-Gut Connection: SIBO and Beyond

One of the most intriguing developments in fibromyalgia research is the emerging connection between gut health and central sensitization. The gut-brain axis, the bidirectional communication highway between the gastrointestinal tract and the central nervous system, appears to be significantly disrupted in fibromyalgia.

A landmark 2004 study by Pimentel et al. found that 100% of fibromyalgia patients in their cohort tested positive for small intestinal bacterial overgrowth (SIBO) using lactulose breath testing. While that 100% figure is likely an overestimate (later studies have found rates of 30-70%), the association between SIBO and fibromyalgia is strong and has been replicated across multiple research groups.

The proposed mechanism: bacterial overgrowth in the small intestine produces excessive lipopolysaccharides (LPS) and other bacterial metabolites. These cross a compromised intestinal barrier (“leaky gut”), enter systemic circulation, and activate immune pathways that drive neuroinflammation and central sensitization. SIBO also impairs absorption of key nutrients, iron, B12, magnesium, vitamin D, that are critical for nervous system function.

The gut-brain link reaches beyond SIBO. Studies have described altered gut microbiome composition in fibromyalgia, and IBS overlaps with up to 70% of patients. The evidence is still associative, which means it shows the two travel together, not that gut changes cause fibromyalgia. Our post on fibromyalgia and gut health walks through testing and diet trials in more depth.

Understanding Fibromyalgia Flare-Ups

A fibromyalgia flare-up is a temporary but significant worsening of symptoms, often pain, fatigue, and cognitive dysfunction all spike simultaneously. Flares can last hours to weeks, and they are one of the most frustrating aspects of living with the condition because they can erase weeks of progress.

Common flare triggers include:

• Physical overexertion: The “boom-bust” cycle, doing too much on a good day, then crashing for days afterward
• Emotional stress: Cortisol and catecholamine surges directly upregulate central sensitization
• Sleep disruption: Even one night of poor sleep can lower pain thresholds measurably
• Weather changes: Barometric pressure drops and cold/damp conditions are commonly reported triggers (the mechanism is unclear but real for many patients)
• Infections: Viral and bacterial infections trigger immune activation that can exacerbate neuroinflammation
• Hormonal fluctuations: Many women report premenstrual flares; perimenopause often worsens fibromyalgia significantly

Flare management strategies: pace activities aggressively, prioritize sleep hygiene, use gentle heat (warm baths, heating pads), practice diaphragmatic breathing to activate the parasympathetic nervous system, and avoid the temptation to “push through.” Flares are temporary, but pushing through them risks extending their duration. A flare log, noting sleep, activity, stress, weather and menstrual timing, often reveals a personal pattern within a few weeks. Step-by-step flare plans are in our post on fibromyalgia flare-ups.

Fibromyalgia Prognosis: What to Expect Over Time

The prognosis for fibromyalgia is variable but generally stable or improving with treatment. Fibromyalgia does not destroy joints, damage organs or progress the way rheumatoid arthritis or multiple sclerosis can. Studies show that 25-50% of patients experience significant long-term improvement with multimodal treatment, and an estimated 10-25% no longer meet the diagnostic criteria years later.

Does fibromyalgia get better or worse with age?

Fibromyalgia usually follows a fluctuating course rather than a steady decline. Symptoms tend to rise during periods of poor sleep, stress, illness, inactivity or hormonal change such as perimenopause, and settle when those pressures ease. Children and teenagers with juvenile fibromyalgia have a better outlook than adults: up to 80% show significant improvement over 2 to 4 years.

What predicts a better fibromyalgia outcome?

The patients most likely to improve share a handful of habits and circumstances. The factors linked to better long-term outcomes include:

• Regular, paced exercise that continues after the first few difficult months
• Restorative sleep, including treatment of sleep apnea or restless legs when present
• Treatment of overlapping conditions such as IBS, POTS, hypothyroidism, depression and anxiety
• Lower pain catastrophizing, often built through CBT or acceptance-based therapy
• An early diagnosis, which shortens the years spent searching for answers

Large cohort studies have found higher rates of suicide and accidental death among people with fibromyalgia than in the general population, even though the condition does not damage tissue. That is a reason to treat mood, sleep and medication safety as part of fibromyalgia care, not as separate problems. If you are thinking about suicide, call or text 988 in the United States to reach the 988 Suicide and Crisis Lifeline.

Can you work with fibromyalgia?

Many people with fibromyalgia keep working, often with adjustments such as flexible hours, rest breaks, remote days or a sit-stand desk. Others reduce hours or stop for a period during severe symptoms. In the United States, the Social Security Administration evaluates fibromyalgia under its own ruling, SSR 12-2p, which requires a documented diagnosis and evidence of ongoing limitations. Our post on fibromyalgia and disability covers documentation and the application process.

Who Treats Fibromyalgia and How to Find a Clinic

Fibromyalgia is usually managed by a primary care physician or rheumatologist, with a wider team added as needed. That team can include a pain medicine physician, a neurologist for small-fiber neuropathy or migraine, a physical therapist for graded exercise, a psychologist trained in CBT or ACT for chronic pain, a sleep specialist, and a registered dietitian. Integrative and functional medicine physicians often coordinate the off-label options covered above, such as low-dose naltrexone, hyperbaric oxygen therapy and neurofeedback.

Before booking with any clinic, ask a few concrete questions:

1. Who on the team is licensed to diagnose and prescribe, and in which specialty?
2. Which outcome measures will you track, such as pain scores, the Fibromyalgia Impact Questionnaire (FIQR) or sleep quality?
3. What does the published evidence for this treatment in fibromyalgia actually show, and is it FDA approved for this use?
4. What is the total cost of a full course, is it cash pay, and what is the plan if nothing changes after a set number of weeks?
5. Will you share records with my primary care physician or rheumatologist?

The Regenerated directory lists clinics that offer integrative and regenerative care for chronic pain, and it is free for patients. The order of the list is not paid ranking. Featured slots are clearly labeled and capped, and Verified means the clinic completed credential checks, not that it paid more. Inclusion in the directory is not an endorsement, so use the questions above with every clinic you contact. Our explainer on how Featured, Verified and organic listings differ covers the labels in detail.

Good starting points are the chronic pain treatment guide, which compares integrative approaches across pain conditions, and the chronic fatigue syndrome condition page if post-exertional crashes are part of your picture.

Frequently Asked Questions (FAQ)

Is fibromyalgia an autoimmune disease?

Fibromyalgia is not classified as an autoimmune disease. It does not involve autoantibodies attacking specific tissues the way lupus or rheumatoid arthritis do, and it is defined as a central sensitization syndrome. The line is blurring, though: a 2021 study by Goebel and colleagues showed that IgG antibodies from fibromyalgia patients induced fibromyalgia-like pain sensitivity in mice, and autoantibodies against satellite glial cells have been found in a subset of patients.

Can fibromyalgia go into remission?

Yes. Fibromyalgia is a chronic condition, but 25-50% of patients experience significant long-term improvement with multimodal treatment, and an estimated 10-25% reach full remission, meaning they no longer meet the diagnostic criteria years later. Remission is most likely in people who keep up regular paced exercise, achieve restorative sleep, treat comorbidities such as IBS or POTS, and build stress management and pacing skills.

What is the difference between fibromyalgia and chronic fatigue syndrome (ME/CFS)?

Fibromyalgia is defined mainly by widespread musculoskeletal pain, while ME/CFS is defined mainly by post-exertional malaise (PEM), a disproportionate crash after physical or mental effort. Both involve fatigue, pain, cognitive problems and poor sleep, and about 30-70% of patients with one condition also meet criteria for the other. Many researchers place them on a shared spectrum of central sensitization disorders, so pacing matters for both.

Does fibromyalgia show up on MRI or blood tests?

No. Standard MRI and routine blood tests are typically normal in fibromyalgia, and that normal result is itself a diagnostic clue. Research tools do detect differences: functional MRI shows altered pain processing, PET imaging shows neuroinflammation, and skin biopsy can show reduced small-fiber nerve density. Elevated substance P in spinal fluid and patient IgG antibodies are also measurable, but none of these are used as routine diagnostic tests.

Can children and teenagers get fibromyalgia?

Yes. Juvenile fibromyalgia affects an estimated 1-6% of school-age children, with higher rates in adolescent girls, and it is diagnosed with criteria similar to those used for adults. The outlook is better than in adults: up to 80% of young people with fibromyalgia show significant improvement over 2 to 4 years, especially with early treatment that combines graded exercise, CBT and sleep improvement.

Is fibromyalgia progressive, does it get worse over time?

No. Fibromyalgia is not a degenerative or progressive disease in the way rheumatoid arthritis or multiple sclerosis can be. It does not cause joint destruction or organ damage. Symptoms can still worsen without treatment, usually because of physical deconditioning, worsening sleep, untreated comorbidities and chronic stress. With appropriate multimodal treatment, the course is generally stable or improving over the years.

What role do hormones play in fibromyalgia?

Hormones are a significant modulator of fibromyalgia symptoms. Fibromyalgia is 2-3× more common in women, and many patients notice changes with menstrual cycles, pregnancy and menopause. Estrogen has pain-modulating effects, so falling estrogen in perimenopause often triggers or worsens symptoms. HPA axis dysregulation, low thyroid function and low testosterone in both sexes are also linked to more severe symptoms, so a hormonal workup is worth discussing.

Can I take LDN with my current fibromyalgia medications?

LDN can generally be combined with SNRIs such as duloxetine and milnacipran, with pregabalin, and with most other fibromyalgia medications. The one firm contraindication is opioid use: LDN blocks opioid receptors and can trigger withdrawal, so a washout of 7-14 days is required before starting. Tramadol, which has weak opioid activity, is also incompatible. Review the full medication list with your prescribing physician before starting.

What is the connection between fibromyalgia and POTS?

Postural Orthostatic Tachycardia Syndrome (POTS) and fibromyalgia share autonomic nervous system dysfunction. Up to 70% of POTS patients report chronic pain, and many meet fibromyalgia criteria. Sympathetic overdrive in POTS can amplify central sensitization, while deconditioning from fibromyalgia can worsen orthostatic intolerance. Treating POTS with salt, fluids, compression, graded exercise and medications such as midodrine or ivabradine often eases fibromyalgia symptoms too.

Related Topics

Fibromyalgia intersects with many conditions and therapies. Explore these related guides for deeper information:

• Low-Dose Naltrexone (LDN): The Complete Guide, mechanism, dosing, and evidence for chronic pain and autoimmune conditions
• Brain Fog: Causes, Testing, and Treatment, understanding and treating the cognitive dysfunction that accompanies fibromyalgia
• Small-Fiber Neuropathy Guide, the peripheral nerve condition that overlaps with fibromyalgia in up to 50% of patients
• Neurofeedback Therapy, how EEG biofeedback retrains brain patterns associated with chronic pain
• Hyperbaric Oxygen Therapy (HBOT), the Israeli research and clinical protocols for fibromyalgia
• Mast Cell Activation Syndrome (MCAS), the inflammatory condition that frequently coexists with fibromyalgia
• SIBO: Small Intestinal Bacterial Overgrowth, the gut-brain connection and how treating SIBO can reduce pain
• POTS Treatment Guide, managing the autonomic dysfunction that amplifies fibromyalgia symptoms